For this major Fortune 50 Healthcare company, business is the epitome of complexity. They partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver the right medicines, medical products, and healthcare services to the patients who need them, when they need them—safely and cost-effectively.
There’s no margin for error, but millions of things could go wrong at any time. In just one of many workstreams, 10,000 life-critical line items are processed every hour. Even a simple hospital order (e.g., for gauze pads and insulin) crosses a web of ~30 custom and packaged apps—including SAP ECC, FI, Hybris, Ariba, Salesforce, Workday, Pega—multiple integration platforms, and multiple distribution/delivery systems.
Now, core systems are being updated and released daily, and the packaged app landscape is undergoing a massive 10-year shift to the cloud—including moving 24 SAP instances to SAP S/4HANA. And among all this change, there’s pressure to catch defects earlier and reduce the overall cost of testing.
A major Fortune 50 Healthcare company performed an extensive search for testing solutions that were equipped for their sophisticated IT landscape—both current and future-state. They discovered Tricentis and took up the CEO’s bold challenge: “Give us your most difficult automation challenges, and we’ll prove that we can solve them.” This led to a Proof of Concept where 13 tricky use cases—across both legacy and modern technologies—were successfully completed in three weeks with 5-6 people led by Tricentis Solution Architects. At that point, they were convinced Tricentis was the right partner to provide the technology and guidance needed for fast innovation without business disruption.
The company is currently in the process of implementing the complete Tricentis platform, including:
The Director of Quality Assurance determined that this strategic quality investment will yield a total savings of $750K in the first 5 quarters, then $1.44M annually thereafter.
Phase 1 Goals + Projections
Phase 2 Goals